The antihypertensive efficacy of losartan and amlodipine assessed with office and ambulatory blood pressure monitoring

CMAJ. Canadian Medical Association Journal

Volumn 159, Issue 5, 1998, Pages 469-476

  Wilson, Thomas W ^a,d   Lacourcière, Yves ^b   Barnes, Colin C ^c  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM;

ADULT; AGED; ANKLE EDEMA; ARTICLE; ASTHENIA; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FATIGUE; FEMALE; HEADACHE; HUMAN; HYPERTENSION; LEG EDEMA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTPATIENT DEPARTMENT; RANDOMIZED CONTROLLED TRIAL; SITTING; UPPER RESPIRATORY TRACT INFECTION;

EID: 0032497296     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Collins R, MacMahon S. Blood pressure, antihypertensive drug treatment and the risks of stroke and coronary artery disease. Br Med Bull 1994;50:272-98.
2. Whelton PK, Perneger TV, Brancati FL, Klag MJ. Epidemiology and prevention of blood pressure related renal disease. J Hypertens 1992;10(Suppl):S77-84.
3. Jachuk SJ, Brierley H, Jachuk S, Willcox PM. The effect of hypotensive drugs on the quality of life. J R Coll Gen Pract 1982;32:103-5.
4. Kostis JB, Rosen RC, Brondolo E, Taska L, Smith DE, Wilson AC. Superiority of nonpharmacologic therapy compared to propranolol and placebo in men with mild hypertension: a randomized, prospective trial. Am Heart J 1992;123:466-74.
5. Baba T, Neugebauer S. The link between insulin resistance and hypertension. Effects of antihypertensive and antihyperlipidemic drugs on insulin sensitivity. Drugs 1994;47:383-404.
6. Lind L, Pollare T, Berne C, Lithell H. Long-term metabolic effects of anti-hypertensive drugs. Am Heart J 1994;128:1177-83.
7. Furberg CD, Psaty BM, Meyer JV. Nifedipine. Dose related increase in mortality in patients with coronary artery disease. Circulation 1995;92:1326-31.
8. Packer M, O'Connor CM, Ghali JK, Pressler ML, Carson PF, Belkin RN, et al. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group. N Engl J Med 1996;335:1107-14.
9. Abernethy DR. An overview of the pharmacokinetics and pharmacodynamics of amlodipine in elderly persons with systemic hypertension. Am J Cardiol 1994;73:10A-17A.
10. Lo MW, Goldberg MR, McCrea JB, Lu H, Furtek CI, Bjornsson TD. Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP 3174 in humans. Clin Pharmacol Ther 1995;58:641-9.
11. Pitt B, Segal R, Martinez FA, Meurers G, Cowley AJ, Thomas I, et al. Randomized trial of losartan versus captopril in patients over 65 with heart failure. Evaluation of losartan in the elderly study, ELITE. Lancet 1997;349:747-52.
12. Chan JCN, Critchley JAJ, Lappe JT, Raskin SJ, Snavely D, Goldberg AI, et al. Randomized, double blind, parallel study of the anti-hypertensive efficacy and safety of losartan potassium compared with felodipine ER in elderly patients with mild to moderate hypertension. J Hum Hypertens 1995;9:765-71.
13. MacKay JH, Arcuri KE, Goldberg AI, Snapinn SM, Sweet CS. Losartan and low-dose hydrochlorothiazide in patients with essential hypertension. A double blind placebo controlled trial of concomitant administration compared with individual components. Arch Intern Med 1996;156:278-85.
14. Oparil S, Barr E, Elkins M, Liss C, Vrecenak A, Edelman J. Efficacy, tolerability, and effects on the quality of life of losartan alone, or with hydrochlorothiazide, in patients with essential hypertension. Clin Ther 1996;18:608-25.
15. O'Brien E, O'Malley K, Cox J, Stanton A. Ambulatory blood pressure monitoring in the evaluation of drug efficacy. Am Heart J 1991;121:999-1006.
16. Cheung DG, Gasster JL, Weber MA. Assessing duration of antihypertensive effects with whole-day blood pressure monitoring. Arch Intern Med 1989;149:2021-5.
17. Haynes RB, Lacourcière Y, Rabkin SW, Leenen FHH, Logan AG, Wright N, et al. Report of the Canadian Hypertension Society Consensus Conference: 2. Diagnosis of hypertension in adults. CMAJ 1993;149:409-18.
18. Dimenäs E, Wallander MA, Svärdsudd k, Wiklund I. Aspects of the quality of life on treatment with felodipine. Eur J Clin Pharmacol 1991;40:141-7.
19. Waeber B, Rutschmann B, Nussberger J, Brunner HR. Evaluation of antihypertensive therapy: differences between office and ambulatory recorded blood pressure. J Hypertens 1991;9(Suppl 3):S53-6.
20. Lacourcière Y, Leenen FHH, Rangno R, Spence JD, Lenis J, Myers M. Discrepancies between clinic and ambulatory responses to cilazapril therapy. Can J Cardiol 1994;10:605-10.
21. Medical Research Council Working Group. MRC trial of treatment of mild hypertension: principal results. BMJ 1985;291:97-114.
22. Neaton JD, Grimm RH, Princas RJ, Stamler J, Grandits GA, Elmer PJ, et al. Treatment of mild hypertension study. Final results. JAMA 1993;270:713-24.
23. Stason WB. Economics in hypertension management: costs and quality trade-offs. J Hum Hypertens 1987;5:S55-9.